Trials / Completed
CompletedNCT03512899
Comparison Between Internal Jugular Vein Versus Axillary Vein for Implantable Ports
Internal Jugular Vein Versus Axillary Vein With Single-incision for Implantable Ports: a Prospective and Randomized Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- AC Camargo Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparison between internal jugular vein versus via axillary vein with single-incision for placement of implantable ports in cancer patients. Investigators are recruiting 240 patients and randomizing 120 for each arm. Primary outcome is early complications, until 30 days and secondary outcome late complications, between 30 days and 6 months. The follow-up is 12 months.
Detailed description
Prospective and randomized trial comparing internal jugular vein versus via axillary vein with single-incision for placement of implantable ports in cancer patients. Investigators are recruiting 240 patients and randomizing 120 for each arm in a single center study at AC Camargo Cancer Center. Every surgery is assisted by ultrasound and radioscopic and the catheter is districath®, 8.5 French. Clinical assessment will be at 10 days and every 3 months after surgery. Primary outcome is early complications, until 30 days and secondary outcome late complications, between 30 days and 6 months. The follow-up is 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Right internal jugular access. | Implantation using percutaneous puncture. |
| PROCEDURE | Left internal jugular access. | Implantation using percutaneous puncture. |
| PROCEDURE | Right axillary vein access. | Implantation using percutaneous puncture. |
| PROCEDURE | Left axillary vein access. | Implantation using percutaneous puncture. |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2022-11-01
- Completion
- 2022-11-10
- First posted
- 2018-05-01
- Last updated
- 2023-07-25
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03512899. Inclusion in this directory is not an endorsement.